Clinical Trial Update: Epidermal Growth Factor Receptor Inhibition for Keratinopathies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating epidermal growth factor receptor inhibition for keratinopathy diseases, including Epidermolytic ichthyosis, palmoplantar ker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolytic Ichthyosis
• Pachyonychia Congenita
• Palmoplantar Keratoderma

Snippet

Sponsor: Northwestern University | Conditions: Epidermolytic Ichthyosis, Palmoplantar Keratoderma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING